In this Section |
257531 Marijuana withdrawal associated with aggression in a nationally representative sample of marijuana usersMonday, October 29, 2012
Evidence regarding a direct link between marijuana use and aggression is highly mixed with regard to both direction and significance. Recently, some have speculated that marijuana withdrawal symptoms may cause increased risk of aggression. In this study, we tested the association between marijuana withdrawal symptoms and aggressive behavior (general and relationship aggression) among a nationally representative sample of U.S. adults. We analyzed data from wave two of the National Epidemiologic Survey on Alcohol and Related Conditions. The sample was limited to those who reported using marijuana (n = 1,461) during the past year. We used logistic regression models to examine two outcomes: 1) general aggression since the last interview, and 2) past year relationship aggression. Marijuana abuse/dependence symptoms, age, gender, household income, personality disorder, alcohol use disorder, and drug use disorder (other than marijuana) were included in adjusted models as covariates. We found a significant association between marijuana withdrawal and general aggression (OR = 1.30; p < 0.05), but the association with relationship aggression was not significant. There was a significant age by withdrawal symptoms interaction, in which withdrawal symptoms were associated with relationship aggression among younger adults (OR = 2.53; p < 0.05 for 25 year olds). The interaction between age and withdrawal symptoms was not significant in the general aggression model. Our findings suggest a cross-sectional relationship between marijuana withdrawal symptoms and aggression. Results for younger adults are particularly intriguing because they indicate significant associations for both general aggression and relationship aggression.
Learning Areas:
EpidemiologyPublic health or related research Social and behavioral sciences Learning Objectives: Keywords: Epidemiology, Marijuana
Presenting author's disclosure statement:
Qualified on the content I am responsible for because: As a doctoral candidate, I have experience presenting both posters and papers at national meetings. I have developed expertise in substance use epidemiology, which is the broad topic of this abstract. I received a dissertation grant from the National Institute of Drug Abuse, funding a project of similar content. I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.
Back to: 3387.0: Consequences & Comorbidities: ATOD Studies
|